System1 launches Test Your Ad Screen
RNS Reach
27 August 2026
System1 Group PLC (AIM: SYS1)
("System1", or "the Company", or "the Group")
System1 launches Test Your Ad Screen
New AI-enabled product expands System1's Test Your Ad platform
System1 www.system1group.com, the marketing decision-making platform, is pleased to announce the launch of Test Your Ad Screen, an AI screening tool providing rapid, directional predictions of an advertisement's commercial effectiveness.
This tool has been trained on 18 million real human emotional responses from System1's Test Your Ad Competitive Edge database, which the Company believes to be the world's largest database of human emotional norms. The new tool helps marketers screen up to 100 finished long-form adverts or other pieces of creative material ("creative assets" or "assets") at a time, with results available in approximately 10 minutes.
Results are presented in ranges across key diagnostics, giving a directional and honest read of where an asset's commercial impact is likely to land relative to category and emotional norms. Test Your Ad Screen's predictions match human testing nine times out of ten and the screening tool won't show a result if it lacks confidence in the accuracy of its predictions.
Test Your Ad Screen expands System1's existing product offering, providing a more affordable entry point for new customers and enabling existing clients to assess a greater volume of creative assets. The launch supports the Group's strategy of driving growth through product innovation, customer expansion and new customer acquisition.
James Gregory, CEO of System1 commented: "We believe the future of creative effectiveness lies in combining AI with real human understanding. Test Your Ad Screen is trained on millions of real human emotional responses, not synthetic data or assumptions, which we believe will help marketers screen creative assets quickly while staying grounded in how people actually feel. This is not a replacement for human testing, but a complement to it, and an important next step for System1 in bringing AI and human emotion together. The launch extends the breadth of our Test Your Ad platform, strengthening our offering to customers and supporting growth through continued product innovation."
For further information, please contact:
|
System1 Group PLC |
via Alma |
|
James Gregory, Chief Executive Officer |
|
|
Chris Willford, Chief Financial Officer |
|
|
Canaccord Genuity Limited (Nominated Adviser & Broker) |
Tel: +44 (0)20 7523 8000 |
|
Simon Bridges / Andrew Potts / Harry Rees |
|
|
Alma Strategic Communications |
Tel: +44 (0)20 3405 0205 |
|
Caroline Forde / Hannah Campbell / Rose Docherty |
About System1 Group plc
System1 is a marketing decision-making platform business, utilised by some of the world's largest brands, across 81 markets globally. Since 2000, System1 has helped marketers tap into consumers' emotions to predict and improve the commercial impact of ads and ideas. Drawing on the world's largest database of emotional norms, our advertising and idea tests measure emotion to give our customers the most accurate predictions of the business impact of creativity. We 'predict' (provide research results) and work with our customers to 'improve' (provide insight and consultancy on those results) advertising effectiveness, innovation effectiveness and brand effectiveness.
We work with more than 600 clients, including 48 of the world's top 100 brands by media spend, 5 of the top 10 US and 8 of the top 10 UK advertisers.
Further information on the Company can be found at www.system1group.com.
About Reach announcements
Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE